STOCK TITAN

IntriCon to Announce 2020 First-Quarter Results on Tuesday, May 19, 2020

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

Rhea-AI Summary

IntriCon Corporation (NASDAQ: IIN) will release its Q1 2020 financial results on May 19, 2020, at market close. Management will host a conference call at 4:00 p.m. CT for investors to discuss the results. Callers can join by dialing 866-795-7248 domestically or 470-495-9160 internationally, using conference ID: 6561768. A webcast will be accessible on IntriCon's website. The company specializes in miniature interventional, implantable, and body-worn medical devices, serving the growing demand for compact, connected technologies.

Loading...
Loading translation...

Positive

  • Scheduled Q1 2020 financial results release indicates transparency and communication with investors.
  • Conference call provides an opportunity for investors to engage directly with management.

Negative

  • None.

ARDEN HILLS, Minn., May 11, 2020 (GLOBE NEWSWIRE) -- IntriCon Corporation (NASDAQ: IIN), a designer, developer and manufacturer of miniature interventional, implantable and body-worn medical devices, today announced that it will release its 2020 first-quarter results on Tuesday, May 19, 2020, at market close.

Following the release, IntriCon’s management team will host a conference call on the same day, beginning at 4:00 p.m. CT/5:00 p.m. ET. Investors interested in listening to the conference call may do so by dialing 866-795-7248 for domestic callers or 470-495-9160 for international callers, using conference ID: 6561768. A live and archived webcast will be available on the “Investors” sections of the company’s website at: www.IntriCon.com.

About IntriCon Corporation
Headquartered in Arden Hills, Minn., IntriCon Corporation designs, develops and manufactures miniature interventional, implantable and body-worn medical devices. These advanced products help medical, healthcare and professional communications companies meet the rising demand for smaller, more intelligent and better-connected devices. IntriCon has facilities in the United States, Asia, the United Kingdom and Europe. The company’s common stock trades under the symbol “IIN” on the NASDAQ Global Market. For more information about IntriCon, visit www.intricon.com.

Investor Relations Contact:
Leigh Salvo
(415) 937-5404
InvestorRelations@intricon.com

FAQ

When will IntriCon release its Q1 2020 results?

IntriCon will release its Q1 2020 results on May 19, 2020, at market close.

What time is IntriCon's conference call for Q1 2020 results?

The conference call will take place on May 19, 2020, at 4:00 p.m. CT.

How can I participate in IntriCon's Q1 2020 conference call?

Investors can join the call by calling 866-795-7248 for domestic or 470-495-9160 for international participation, using conference ID: 6561768.

Where can I find IntriCon's Q1 2020 results webcast?

The webcast will be available on IntriCon's website in the 'Investors' section.

What services does IntriCon provide?

IntriCon designs, develops, and manufactures miniature interventional, implantable, and body-worn medical devices.
Intricon

NASDAQ:IIN

IIN Rankings

IIN Latest News

IIN Stock Data

225.49M
8.53M
Medical Instruments & Supplies
Healthcare
Link
United States
Arden Hills